Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for phosphatidylinositol 3- kinases
Most Correlated Studies
- Mantle cell lymphoma (MCL) cells treated with kinase inhibitors
- Human breast cancer cell (T47D) gene expression after treatment with GDC-0941
- HCT116 colorectal carcinoma cells in the presence and absence of tumor suppressor PTEN
- Rcho-1 trophoblast stem cell gene expression after differentiation with or without LY294002
- Embryonic stem cells with Gsk-3a and Gsk-3b double knockout
Most Relevant Literature
- Dendritic cell PIK3C3/VPS34 controls the pathogenicity of CNS autoimmunity independently of LC3-asso…
- Arsenic induces dysfunctional autophagy via dual regulation of mTOR pathway and Beclin1-Vps34/PI3K c…
- Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the …
- PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cel…
- Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatme…
Most Relevant Clinical Trials
- Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
- Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglo…
- Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patie…
- Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cispla…
- A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phos…
